Oncology Clinical Research Scientist – Hematology (Hybrid)

Aequor; Pleasanton (CA); Hybride; USD 83 000 - 131 000; Plein temps

Résumé du poste

Aequor is seeking a hands-on Clinical Research Scientist with oncology experience to support end-to-end clinical trial execution in a hybrid environment (Pleasanton/Princeton). You will review data, ensure protocol adherence, and collaborate with Medical Directors and Operations to maintain safety and quality.

The role emphasizes independent study management, data cleaning, and documentation across Phase I–III oncology programs.

Qualifications

• Requires 3–5 years in drug development within pharma/biotech.
• Minimum 2 years hands-on oncology clinical development experience.
• Experience supporting execution of clinical trials, not biomarker work.
• Strong ability to review comprehensive clinical data including safety and efficacy.

Responsabilités

• Support daily execution of Phase I–III oncology trials with protocols and timelines adherence.
• Review patient enrollment, protocol deviations and ongoing study activities.
• Address site inquiries and monitoring concerns with Medical Directors and Clinical Operations.
• Independently manage assigned study responsibilities across multiple projects.
• Contribute to study protocols, CSRs, IBs and other scientific documents.
• Collaborate with cross-functional teams and provide timely study updates.

Connaissances

Drug development

Oncology clinical development

Clinical trial execution

Data review

EDC systems

Cross-functional collaboration

Formation

MS or PhD in life sciences

PharmD (or related degree)

Outils

Medidata

OpenClinica

Description du poste

Aequor is seeking a hands-on Clinical Research Scientist with oncology experience to support end-to-end clinical trial execution in a hybrid environment (Pleasanton/Princeton). You will review data, ensure protocol adherence, and collaborate with Medical Directors and Operations to maintain safety and quality.

The role emphasizes independent study management, data cleaning, and documentation across Phase I–III oncology programs.